Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 70, Issue 3, Pages 399-405
Publisher
Springer Nature
Online
2012-07-19
DOI
10.1007/s00280-012-1929-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy
- (2011) Takeshi Masuda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation
- (2011) Yosuke Togashi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- High-dose Erlotinib for Refractory Brain Metastases in a Patient with Relapsed Non-small Cell Lung Cancer
- (2011) Akito Hata et al. Journal of Thoracic Oncology
- Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
- (2011) Britta Weber et al. Journal of Thoracic Oncology
- "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
- (2011) C. Grommes et al. NEURO-ONCOLOGY
- Neoplastic Meningitis from Solid Tumors: New Diagnostic and Therapeutic Approaches
- (2011) G. Lombardi et al. ONCOLOGIST
- Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer
- (2010) Young Joo Lee et al. CANCER
- Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation
- (2010) M. A. Elmeliegy et al. CLINICAL CANCER RESEARCH
- Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
- (2010) Luis Paz-Ares et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer
- (2010) Jennifer L. Clarke et al. JOURNAL OF NEURO-ONCOLOGY
- A Case of Radiation Recall Pneumonitis Induced by Erlotinib, Which Can be Related to High Plasma Concentration
- (2010) Yosuke Togashi et al. Journal of Thoracic Oncology
- Carcinomatous Meningitis in Non–Small-Cell Lung Cancer: Response to High-Dose Erlotinib
- (2009) Nirav Dhruva et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib
- (2009) Tatsuya Katayama et al. Journal of Thoracic Oncology
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Successful Treatment of Carcinomatous Meningitis with Gefitinib in a Patient with Lung Adenocarcinoma Harboring a Mutated EGF Receptor Gene
- (2008) Tatsuro Fukuhara et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now